Page last updated: 2024-10-26

dipyridamole and Herpes Simplex Virus Infection

dipyridamole has been researched along with Herpes Simplex Virus Infection in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Passer, BJ1
Cheema, T1
Zhou, B1
Wakimoto, H1
Zaupa, C1
Razmjoo, M1
Sarte, J1
Wu, S1
Wu, CL1
Noah, JW1
Li, Q1
Buolamwini, JK1
Yen, Y1
Rabkin, SD1
Martuza, RL1

Other Studies

1 other study available for dipyridamole and Herpes Simplex Virus Infection

ArticleYear
Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.
    Cancer research, 2010, May-15, Volume: 70, Issue:10

    Topics: Animals; Combinatorial Chemistry Techniques; Dilazep; Dipyridamole; Equilibrative Nucleoside Transpo

2010